AGXT and primary hyperoxaluria type 1: In patients with PH1, AGXT gene mutations lead to deficiency in the alanine-glyoxylate aminotransferase (AGT) enzyme, which catalyzes the conversion of glyoxylate to glycine in the liver (7).